The ACER-study - the effects of galantamine on the variability and stability of walking among patients with Alzheimer's disease. De ACER-studie - effecten van galantamine op de variabiliteit en stabiliteit van het looppatroon bij patienten met de ziekte van Alzheimer.

Trial Profile

The ACER-study - the effects of galantamine on the variability and stability of walking among patients with Alzheimer's disease. De ACER-studie - effecten van galantamine op de variabiliteit en stabiliteit van het looppatroon bij patienten met de ziekte van Alzheimer.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Galantamine (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacodynamics
  • Acronyms ACER
  • Most Recent Events

    • 06 Nov 2012 Last checked against European Clinical Trials Database.
    • 27 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top